MeSH tree: C20.111
For people with multiple sclerosis (PwMS), within-person reductions in daytime activity patterns precede clinical disability worsening, according to a study published online March 4 in Neurology.
1 hour ago
0
0
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...
4 hours ago
0
0
Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a result, patients with T1D must closely monitor their blood glucose (BG) levels and rely on insulin ...
Mar 9, 2026
0
0
A new study published in Neurology, led by Queen Mary University of London, has revealed that people of South Asian, African and European ancestry share many of the same genetic risk factors for multiple sclerosis (MS).
Mar 9, 2026
0
1
Our immune system relies on T cells to fight infections. But T cells don't just show up and react—first, they train, get a game plan, and coordinate their defenses in lymphoid organs. Researchers have struggled to understand ...
Mar 5, 2026
0
0
What type of medical intervention is approved by the U.S. Food and Drug Administration across different devices and indications to help treat conditions as disparate as epilepsy, stroke rehabilitation, depression, migraine, ...
Mar 5, 2026
0
0
Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and loss of brain volume, according to a study published in Neurology. The study found that people with ...
Mar 4, 2026
0
0
Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide. Using mass spectrometry, ...
Mar 2, 2026
0
0
The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or older should receive a protein subunit Respiratory Syncytial Virus (RSV) vaccine and those aged ...
Mar 2, 2026
0
0
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research published in The Journal of ...
Mar 2, 2026
0
0
